Cue Health (HLTHQ) Stock Price
Cue Health Price
Over the last 4 years Cue Health grew revenue by 81.1% annually, reaching 70.94 M USD. For Cue Health, the net margin of -526.5% is down versus -312.1% a few years ago.
Cue Health stock price
Cue Health business model & stock analysis
Frequently asked questions about Cue Health
The business model of Cue Health Inc is centered around the development and commercialization of diagnostic products for professional and consumer use. Cue Health Inc focuses on molecular diagnostics, leveraging biotechnology, software, and engineering to provide rapid and accurate results. By combining portable and easy-to-use platforms with a wide range of applications, Cue Health Inc aims to empower individuals and healthcare professionals with point-of-care testing solutions. With a focus on user-friendly devices and actionable information, Cue Health Inc strives to improve healthcare outcomes and enhance access to timely and accurate diagnostics.
Cue Health Inc is primarily active in the healthcare industry.
The main competitors of Cue Health Inc in the market include reputable companies such as Abbott Laboratories, Becton, Dickinson and Company (BD), and Roche Diagnostics.
Cue Health Inc is a renowned company specializing in healthcare technology solutions. Established in [year], Cue Health Inc has been at the forefront of developing innovative products for diagnostics and disease monitoring. The company's cutting-edge platform combines advanced molecular diagnostics with user-friendly devices, empowering individuals to take control of their health. With a strong emphasis on accuracy, convenience, and accessibility, Cue Health Inc has built a reputation for delivering reliable and timely results. This commitment to innovation has earned the company widespread recognition and numerous accolades in the healthcare industry. Cue Health Inc continues to revolutionize the way healthcare is delivered, providing individuals and healthcare professionals with valuable tools to make informed decisions and improve overall well-being.
Cue Health Inc has achieved several significant milestones. Notably, the company received Emergency Use Authorization from the U.S. FDA for its rapid, portable COVID-19 test. Cue Health Inc also secured a partnership with the U.S. Department of Health and Human Services to produce and distribute COVID-19 tests. Moreover, the company successfully completed a $100 million funding round, allowing for further expansion and development of its innovative technologies. Additionally, Cue Health Inc has received recognition for its advancements in diagnostics, including winning the 2020 Fast Company's Innovation by Design Award.
Cue Health Inc is primarily present in the United States of America (USA).
Cue Health Inc represents a commitment to improving healthcare access and outcomes. The company's corporate philosophy revolves around technological innovation, convenience, and empowering individuals to take control of their health. By developing portable diagnostic devices and digital health solutions, Cue Health aims to democratize healthcare by providing accurate and timely results at the point of care. With a focus on collaborations and partnerships, Cue Health Inc strives to leverage its cutting-edge technology to revolutionize the way healthcare is delivered. This dedication to innovation and accessibility makes Cue Health Inc a leading player in the healthcare industry.
8 analysts currently rate the Cue Health stock: 0 recommend buying, 3 holding and 5 selling. For 2026, analysts expect Cue Health to generate revenue of 213.56 M USD and earnings per share of -0.22 USD.
Converted at the current exchange rate, the Cue Health share trades at 0.00 EUR (0.00 USD).
The Cue Health share (HLTHQ) is listed on 1 stock exchanges, including: NASDAQ (HLTH).
Cue Health Inc is a company specializing in the development of innovative medical devices and services that allow for rapid and accurate diagnosis of infectious diseases and other conditions. The company was founded in 2010 and is headquartered in San Diego, California. Cue Health has multiple business segments, including diagnostics, digital health, consumer health products, clinical trials, and distributors. These business segments offer a wide range of products and services for various markets and customers. One of Cue Health's core areas is the development and manufacturing of diagnostic devices for use in clinical practice and home use. Cue Health's flagship product is the Cue Health Monitoring Test, a handheld device that enables self-testing for a variety of health conditions, including COVID-19, influenza, and Strep-A diseases. The test can provide accurate results within minutes, speeding up decision-making for medical personnel and improving healthcare for patients. Another business segment of Cue Health is digital health. The company develops apps and platforms for remote medical monitoring and surveillance. For example, the company has developed an app that allows users to manage their health data and test results on their mobile devices. The platform also enables remote monitoring by medical professionals, which can improve patient care and treatment. Cue Health also has a consumer health product line that focuses on the needs and health issues of consumers. These products are sold in retail stores and online and include a variety of health and wellness products such as vitamins, supplements, and pain relievers. Another important business segment of Cue Health is supporting clinical trials by providing diagnostic devices and services. By collaborating with medical researchers and companies, Cue Health can play a crucial role in accelerating the development of new drugs and therapies. In addition to its business segments, Cue Health is also a major distributor of medical devices and accessories. The company works with other industry leaders to offer its customers a comprehensive range of health products and services. Overall, Cue Health has a wide range of business segments and products. The company aims to improve people's lives through better healthcare and technology. With its innovative products and services, Cue Health has taken on an important role in improving global healthcare and is expected to continue growing and expanding in the coming years.
The expected revenue of Cue Health is 213.56 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Cue Health is -33.59 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Cue Health is currently -0.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Cue Health stock.
The price-to-sales ratio (P/S) of Cue Health is currently 0.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Cue Health stock.
The Eulerpool Quality Score for Cue Health is 2/10.
The ISIN of Cue Health is US2297901009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Cue Health is HLTHQ. The ticker symbol is used to trade Cue Health shares on the stock exchange.
Cue Health stock
Cue Health Peer Group
Cue Health Ticker
Cue Health FIGI
All fundamentals and in-depth analysis of Cue Health
Our stock analysis for Cue Health stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cue Health. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.